Kasuga M, Akanuma Y, Tsushima T, Suzuki K, Kosaka K, Kibata M
J Clin Endocrinol Metab. 1978 Jul;47(1):66-77. doi: 10.1210/jcem-47-1-66.
We have studied the effects of the serum from a patient with an unusual form of diabetic syndrome with extreme insulin resistance on the metabolism of rat adipocytes in vitro. This serum and IgG fractions from it inhibited the [125I]insulin binding to isolated adipocytes and stimulated the 2-deoxyglucose uptake, glucose oxidation, and the incorporation of amino acids into protein. In addition, these fractions inhibited the lipolysis induced by beta 1-24 ACTH in isolated adipocytes. The insulin-like effects of this serum and the effects of insulin were not additive at their maximal concentrations. The inhibition of [125I]insulin binding was due to a decrease in receptor affinity rather than to a change in receptor number by Scatchard plot analysis. Both the inhibition of insulin binding and the insulin-like effects on rat adipocytes were neutralized by antihuman IgG. In addition, these insulin-like effects were abolished by trypsin treatment of adipocytes. These facts suggest that this serum has a circulating antibody directed at or near the insulin receptor itself and that this antibody mimics the insulin effect on rat adipocytes by binding to the insulin receptor in vitro.
我们研究了一位患有特殊形式糖尿病综合征且具有极端胰岛素抵抗的患者血清对体外培养的大鼠脂肪细胞代谢的影响。该血清及其IgG组分抑制了[125I]胰岛素与分离的脂肪细胞的结合,并刺激了2-脱氧葡萄糖摄取、葡萄糖氧化以及氨基酸掺入蛋白质的过程。此外,这些组分还抑制了β1-24促肾上腺皮质激素在分离的脂肪细胞中诱导的脂解作用。在最大浓度时,该血清的胰岛素样作用与胰岛素的作用并非相加的。通过Scatchard作图分析,[125I]胰岛素结合的抑制是由于受体亲和力降低,而非受体数量改变。胰岛素结合的抑制以及对大鼠脂肪细胞的胰岛素样作用均被抗人IgG中和。此外,通过对脂肪细胞进行胰蛋白酶处理,这些胰岛素样作用被消除。这些事实表明,该血清具有一种针对胰岛素受体本身或其附近的循环抗体,并且这种抗体在体外通过与胰岛素受体结合来模拟胰岛素对大鼠脂肪细胞的作用。